Different Tests for Different Breasts With GE Healthcare ABUS
October 1, 2014
Different Tests for Different Breasts
Ladies, yes, you are intelligent creatures. But “Are You Dense”? Even though public awareness of Breast Cancer has never been greater, a surprising 47-percent of women don’t know the answer to this question – in fact, they’ve never asked, or been asked. But the statistics on Breast Density are staggering: 40-percent of American women have dense breasts, and having dense breasts increases the likelihood of developing cancer by 4-6 times. Unfortunately, both dense breast tissue and cancerous growths show up white on a mammogram, which is why mammography may miss over 1/3 of cancers in dense breasts. Currently, the Invenia Automated Breast Ultrasound, or ABUS, is the only FDA-approved technology for dense breast screenings. Cancer shows up dark on ultrasound, and the automated ABUS. Join Breast Cancer Survivor and Advocate Dr. Rachel Brem for this potentially life-saving special report that helps raise public awareness on breast density, early breast cancer detection and early diagnosis.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.